 President, I ask unanimous consent that the Committee on the Judiciary be authorized to meet to conduct a hearing on ``Paying Off Generics to Prevent Competition with Brand Name Drugs: Should it Be Prohibited?'' on Wednesday, January 17, 2007, at 10:00 a.m. in Dirksen Senate Office Building room 226.                              Witness List  Panel I: Hon. Jon Leibowitz, Commissioner, Federal Trade Commission, Washington, DC.  Panel II: Billy Tauzin, CEO, PhRMA, Washington, DC; Merril Hirsh Partner, Ross, Dixon, and Bell LLP, Washington, DC; Bruce Downey, Chairman and CEO, Barr Pharmaceuticals, Inc., Washington, DC; Michael Wroblewski, Consumers Union, Non-Profit Publisher of Consumer Reports, Yonkers, NY.  